Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10486-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10486-1-AP, RRID:AB_2129996
- Product name
- JUNB antibody
- Antibody type
- Polyclonal
- Description
- JUNB antibody (Cat. #10486-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Low-frequency electroacupuncture exerts antinociceptive effects through activation of POMC neural circuit induced endorphinergic input to the periaqueductal gray from the arcuate nucleus.
MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B.
MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration.
Single-cell analysis of spinal cord injury reveals functional heterogeneity of oligodendrocyte lineage cells.
An innovative immunotherapeutic strategy for rheumatoid arthritis: Selectively suppressing angiogenesis and osteoclast differentiation by fully human antibody targeting thymocyte antigen-1.
Identification of key modules and candidate genes associated with endometriosis based on transcriptome data via bioinformatics analysis.
Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways.
Systematic Survey of the Regulatory Networks of the Long Noncoding RNA BANCR in Cervical Cancer Cells.
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.
USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein.
Wang Q, Li Z, Nie D, Mu X, Wang Y, Jiang Y, Zhang Y, Lu Z
Molecular pain 2024 Jan-Dec;20:17448069241254201
Molecular pain 2024 Jan-Dec;20:17448069241254201
MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B.
Phatak P, Tulapurkar ME, Burrows WM, Donahue JM
Cancers 2023 Sep 30;15(19)
Cancers 2023 Sep 30;15(19)
MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration.
Du J, Liao W, Wang H, Hou G, Liao M, Xu L, Huang J, Yuan K, Chen X, Zeng Y
Signal transduction and targeted therapy 2023 Sep 15;8(1):351
Signal transduction and targeted therapy 2023 Sep 15;8(1):351
Single-cell analysis of spinal cord injury reveals functional heterogeneity of oligodendrocyte lineage cells.
Wu Z, Li G, Wang S, Zhang N, Li X, Zhang F, Niu J, Wang N, Zu J, Wang Y
Gene 2023 Nov 30;886:147713
Gene 2023 Nov 30;886:147713
An innovative immunotherapeutic strategy for rheumatoid arthritis: Selectively suppressing angiogenesis and osteoclast differentiation by fully human antibody targeting thymocyte antigen-1.
Hu X, Li M, Zhang Y, Sang K, Zhang Y, Li W, Liu B, Wan L, Du B, Qian J, Meng F, Fu Y, Dai M, Gao G, Ye H
Experimental cell research 2023 Mar 1;424(1):113490
Experimental cell research 2023 Mar 1;424(1):113490
Identification of key modules and candidate genes associated with endometriosis based on transcriptome data via bioinformatics analysis.
Zheng W, Xiang D, Wen D, Luo M, Liang X, Cao L
Pathology, research and practice 2023 Apr;244:154404
Pathology, research and practice 2023 Apr;244:154404
Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways.
Cai J, Liang J, Zhang Y, Shen L, Lin H, Hu T, Zhan S, Xie M, Liang S, Xian M, Wang S
Pharmacological research 2022 Jun;180:106230
Pharmacological research 2022 Jun;180:106230
Systematic Survey of the Regulatory Networks of the Long Noncoding RNA BANCR in Cervical Cancer Cells.
Wang B, Wang M, Jia S, Li T, Yang M, Ge F
Journal of proteome research 2022 Apr 1;21(4):1137-1152
Journal of proteome research 2022 Apr 1;21(4):1137-1152
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.
Zhao WS, Yan WP, Chen DB, Dai L, Yang YB, Kang XZ, Fu H, Chen P, Deng KJ, Wang XY, Xie XW, Chen HS, Chen KN
American journal of cancer research 2019;9(6):1183-1200
American journal of cancer research 2019;9(6):1183-1200
USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein.
Chen S, Yun F, Yao Y, Cao M, Zhang Y, Wang J, Song X, Qian Y
The Journal of experimental medicine 2018 Nov 5;215(11):2850-2867
The Journal of experimental medicine 2018 Nov 5;215(11):2850-2867
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- MCF7 cells were subjected to SDS PAGE followed by western blot with 10486-1-AP(JUNB antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The JUNB antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human JUNB. This antibody recognizes human, mouse, rat antigen. The JUNB antibody has been validated for the following applications: ELISA, WB, IHC analysis.